What is the recommended dosing for duloxetine (Cymbalta)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duloxetine (Cymbalta) Dosing Recommendations

The recommended dosing for duloxetine is 30 mg once daily for one week, then increasing to 60 mg once daily as the standard therapeutic dose for most indications, with specific adjustments based on the condition being treated. 1, 2

Initial Dosing and Titration

  • Start with 30 mg once daily for 1 week before increasing to 60 mg once daily to reduce the risk of nausea and improve initial tolerability 2
  • Taking duloxetine with food can further improve tolerability, particularly when starting at higher doses 3
  • For most indications, 60 mg once daily is the standard effective therapeutic dose 1, 2

Condition-Specific Dosing

Diabetic Peripheral Neuropathic Pain

  • Standard dose: 60 mg once daily 1, 2
  • There is no evidence that doses higher than 60 mg daily provide additional benefit for neuropathic pain 1, 4
  • Duration of adequate trial: 4 weeks 2

Fibromyalgia

  • Start with 30 mg once daily for 1 week, then increase to 60 mg once daily 1
  • Maximum dose: 60 mg once daily (higher doses don't confer additional benefits but increase adverse effects) 1, 4

Chronic Musculoskeletal Pain

  • Start with 30 mg once daily for 1 week, then increase to 60 mg once daily 1
  • Maximum dose: 60 mg once daily 1, 4

Major Depressive Disorder and Generalized Anxiety Disorder

  • Target dose: 60 mg once daily 1, 5
  • Some patients may require up to 120 mg daily (in divided doses) 1, 5
  • For geriatric patients, start with 30 mg once daily for 2 weeks before considering an increase 1

Special Populations

Renal Impairment

  • For patients with renal insufficiency, consider a lower starting dose and gradual titration 1, 2
  • Avoid use in severe renal impairment (GFR <30 mL/minute) 1

Hepatic Impairment

  • Avoid use in patients with chronic liver disease or cirrhosis 1

Geriatric Patients

  • Start with 30 mg once daily for 2 weeks before considering dose increases 1
  • Titrate more slowly in elderly patients 2

Discontinuation

  • Gradual dose reduction rather than abrupt discontinuation is recommended to minimize withdrawal symptoms 1
  • Common discontinuation symptoms include dizziness, headache, nausea, paresthesia, irritability, anxiety, and fatigue 1, 6

Drug Interactions and Precautions

  • Do not use with MAOIs - allow at least 14 days between discontinuing an MAOI and starting duloxetine 1
  • Allow at least 5 days after stopping duloxetine before starting an MAOI 1
  • Avoid concomitant use with potent CYP1A2 inhibitors 1, 6
  • Use with caution in patients taking medications metabolized by CYP2D6, particularly those with narrow therapeutic indices 6

Common Adverse Effects

  • Most common: nausea, dry mouth, headache, constipation, dizziness, and fatigue 5, 7
  • Most adverse effects are mild to moderate in severity 6
  • Nausea is the most common side effect but occurs less frequently when treatment is initiated at 30 mg daily and gradually titrated 7

Clinical Pearls

  • Pain relief can begin within one week at the 60 mg daily dose 7
  • Duloxetine does not typically produce clinically important electrocardiographic or blood pressure changes 2
  • Routine aminotransferase monitoring is generally unnecessary 2
  • Duloxetine has a generally favorable side effect profile compared to other medications used for neuropathic pain 7, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.